Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Total Current Liabilities (2020 - 2025)

Selectis Health's Total Current Liabilities history spans 9 years, with the latest figure at $25.3 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $25.3 million for Q4 2025, up 28.77% from a year ago — trailing twelve months through Dec 2025 was $25.3 million (up 28.77% YoY), and the annual figure for FY2025 was $25.3 million, up 28.77%.
  • Total Current Liabilities for Q4 2025 was $25.3 million at Selectis Health, up from $20.3 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $25.3 million in Q4 2025 to a low of $4.7 million in Q3 2022.
  • The 5-year median for Total Current Liabilities is $16.9 million (2021), against an average of $15.4 million.
  • The sharpest move saw Total Current Liabilities plummeted 55.22% in 2022, then skyrocketed 214.02% in 2023.
  • Year by year, Total Current Liabilities stood at $11.8 million in 2021, then plummeted by 41.9% to $6.8 million in 2022, then surged by 164.97% to $18.1 million in 2023, then increased by 8.16% to $19.6 million in 2024, then grew by 28.77% to $25.3 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $25.3 million, $20.3 million, and $21.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.